oncbiomune.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: | ||
Meta Tags
| Title | OncBioMune Pharmaceuticals Inc. | OncBioMune Pharmaceuticals - |
| Description | SPECIALIZING Committed to answers for cancer Stock Ticker: OBMP Home Investors Press Releases Stock Information Events and Presentations SEC Filings Social Media Discl |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.136.79 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
oncbiomune.com Valuation
|
US$1,735,886
Last updated: 2023-05-01 04:46:48
oncbiomune.com has Semrush global rank of 6,097,351. oncbiomune.com has an estimated worth of US$ 1,735,886, based on its estimated Ads revenue. oncbiomune.com receives approximately 200,295 unique visitors each day. Its web server is located in United States, with IP address 172.67.136.79. According to SiteAdvisor, oncbiomune.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,735,886 |
| Daily Ads Revenue | US$1,603 |
| Monthly Ads Revenue | US$48,071 |
| Yearly Ads Revenue | US$576,849 |
| Daily Unique Visitors | 13,353 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| oncbiomune.com. | A | 299 | IP: 172.67.136.79 |
| oncbiomune.com. | A | 299 | IP: 104.21.94.131 |
| oncbiomune.com. | AAAA | 299 | IPV6: 2606:4700:3034::ac43:884f |
| oncbiomune.com. | AAAA | 299 | IPV6: 2606:4700:3034::6815:5e83 |
| oncbiomune.com. | NS | 86400 | NS Record: tom.ns.cloudflare.com. |
| oncbiomune.com. | NS | 86400 | NS Record: thea.ns.cloudflare.com. |
HtmlToTextCheckTime:2023-05-01 04:46:48
| Committed to answers for cancer Stock Ticker: OBMP Home Investors Press Releases Stock Information Events and Presentations SEC Filings Social Media Disclosure About Us Pipeline ProscaVax Breast Cancer Innovative Chemotherapy Antisense Email Alerts Contact Loading... SPECIALIZING IN innovative cancer research learn more Home admin 2019-07-15T14:10:32+00:00 Welcome to OncBioMune Pharmaceuticals Inc. We are a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to selectively attack cancer cells without harm to the patient. The vaccine technology has been proven safe through use in more than 300 patients without a single serious adverse event. Our lead product, ProscaVax™ for prostate cancer, has successfully completed a Phase 1a trial funded by the Department of Defense Navy Cancer Vaccine Program. Based upon data showing ProscaVax is non-toxic |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 21:10:51 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Sat, 23 Oct 2021 22:10:51 GMT
Location: https://oncbiomune.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=66LnSvKRA3zY0BESF%2B6QR1DYY%2FH6SuAnobqsNwc2CELQXl8bG%2BwYLIBqWL9dPXJkGBUyHAwdP01tB42tWy55BUxmtEyQPJhSGiHUXZJQk4pQec0GUi1IjU4vBp1p27Euyw%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a2df45ada852d79-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Sat, 23 Oct 2021 21:10:51 GMT
content-type: text/html
last-modified: Thu, 28 Jan 2021 09:17:21 GMT
vary: Accept-Encoding
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=8HAjnaYJIVZjymnLsLzFIffk472k0AvHarlpCT00TCnD%2BN04s%2BG3izWSKSnhFTA4wyAuNUaVbwmiVkv%2Fa6jfQrB%2BQmXQnwsiHTTUuud57QSEjuzzwiUqFJydvVO8VRaAsg%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a2df45b29526366-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
oncbiomune.com Whois Information
Domain Name: ONCBIOMUNE.COM Registry Domain ID: 280009697_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2021-05-07T13:23:42Z Creation Date: 2005-12-09T17:14:09Z Registry Expiry Date: 2022-12-09T17:14:09Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: THEA.NS.CLOUDFLARE.COM Name Server: TOM.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T06:38:36Z <<< |